Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biother...
Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity | AZTR Stock News
Francisco D. Salva Discloses Investment at Azitra, Inc. with 9.99% Stake
U.S. stock market midday update: Azitra down 11.26% with increased volume, no positive support, capital speculation causing fluctuations
Top Biotech Gainers: TNON Files S-1, NVCT Inks License Deal, FTH On Watch, RGNX To Resubmit BLA
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?